Ketamine Recruiting Phase 3 Trials for Treatment Resistant Depressive Disorder Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02556606Ketamine for Treatment Resistant Late-Life Depression